English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA Penn State College of Medicine research team will continue to work on developing a vaccine for COVID-19 using more than $400,000 in funding from the Pennsylvania Department of Community and Economic Development.
Tag: COVID-19 Vaccine
Rutgers Expert Available to Discuss Drug Companies’ Safety Pledge on COVID-19 Vaccine Quest
Michael Gusmano, a Rutgers bioethicist and health policy expert, is available to discuss the pledge by drug manufacturers to uphold ethical standards and scientific principles in the global quest for a COVID-19 vaccine. “The safety pledge indicates the pharmaceutical industry…
Rutgers Bioethicist Available to Discuss Who May Get COVID-19 Vaccine First
Rutgers scholar Nir Eyal is available to discuss the ethics around who will be among the first in line to receive a COVID-19 vaccine when it’s available to the public. “Unlike other therapy treatments, vaccines help prevent the spread of…
Investigational COVID-19 vaccine candidate prevents severe clinical disease in animals
In new research published in Nature Medicine, Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, and colleagues demonstrated that the optimal vaccine elicited robust immune response in Syrian golden hamsters and prevented severe clinical disease — including weight loss, pneumonia and death.
Experimental vaccine that boosts antigen production shows promise against COVID-19
A bioengineering technique to boost production of specific proteins could be the basis of an effective vaccine against the novel coronavirus that causes COVID-19, new research suggests.
Hackensack Meridian Health Enrolling Individuals for COVID-19 Vaccine Clinical Trial
Hackensack Meridian Health investigators expect to enroll 300 individuals.
COVID-19 Vaccine Candidate Tested at University of Kentucky Shows Positive Preclinical Results
PDS Biotechnology, a clinical stage immunotherapy company, has announced positive results from preclinical testing conducted at the University of Kentucky College of Medicine of its COVID-19 vaccine candidate, PDS0203.
George Washington University to Conduct Clinical Trial for COVID-19 Experimental Vaccine
The George Washington University will participate in a clinical trial for an investigational COVID-19 vaccine.
Scientists Identify Targets for COVID-19 Vaccine Using Cancer Immunotherapy Tools
Cancer researchers at Children’s Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine, employing the same approach used to elicit an immune response against cancer cells to stimulate an immune response against the virus. Using this strategy, the researchers believe a resulting vaccine would provide protection across the human population and drive a long-term immune response.
NYU Langone Among First to Enroll Patients In Clinical Trial for COVID-19 Monoclonal Antibody Treatment
The first patients were treated as part of a clinical trial testing whether an antibody therapy can safely reduce COVID-19 disease severity. The experimental treatment consists of identical copies of an antibody, a blood protein related to those that occur naturally as part of the human immune system, researchers say.
Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Project
The internationally-renowned Gene Therapy Program at the University of Pennsylvania is joining the AAVCOVID vaccine program led by Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham. AAVCOVID is a unique gene-based vaccine candidate designed to protect against SARS-CoV-2, the virus that causes COVID-19.
AAVCOVID Vaccine Program Expands Manufacturing Agreements with Gene Therapy Industry Partners Viralgen, Aldevron, and Catalent
The AAVCOVID vaccine program at Massachusetts Eye and Ear and Massachusetts General Hospital has entered into manufacturing agreements with Viralgen, Aldevron and Catalent in order to support manufacturing of the experimental vaccine for clinical studies in the second half of 2020.
In victory over polio, hope for the battle against COVID-19
Medicine’s great triumph over polio holds out hope we can do the same for COVID-19, two researchers say.